Transurethral microwave thermotherapy: The gold standard for minimally invasive therapies for patients with benign prostatic hyperplasia?

Journal of Endourology

Volumn 17, Issue 4, 2003, Pages 245-251

  De La Rosette, Jean J M C H ^a,b   Laguna, M Pilar ^a   Gravas, Stavros ^a   De Wildt, Michel J A M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANESTHETIC AGENT;

ARTICLE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; HEMATURIA; HUMAN; MALE; MORBIDITY; PAIN; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RETROGRADE EJACULATION; SAFETY; STANDARD; STENT; TRANSURETHRAL MICROWAVE THERMOTHERAPY; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; URINARY TRACT INFECTION; URINE RETENTION;

EID: 0037644625     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/089277903765444393     Document Type: Article

References (45)

1. Chapple CR. Introduction and concluding remarks: BPH disease management. Eur Urol 1999;36:1-6.
2. McCaskey D. Quartz light therapy in obstinate prostatic affections. NY Med J 1921;113:647-648.
3. Webb JC, Mucklow SL. Non operative treatment of the senile prostate. Lancet 1931;220:957-960.
4. Laguna MP, Muschter R, Debruyne FMJ. Microwave thermotherapy: Historical overview. J Endourol 2000;14:603-610.
5. Bolmsjo M, Wagrell L, Hallin A, et al. The heat is on - but how? A comparison of TUMT devices. Br J Urol 1996;78:564-572.
6. Blute ML, Tomera KM, Hellerstein DK, et al. Transurethral microwave thermotherapy for management of benign prostatic hyperplasia: Results of the United States Prostatron Cooperative Study. J Urol 1993;150:1591-1596.
7. Dahlstrand C, Walden M, Geirsson G, Pettersson S. Transurethral microwave thermotherapy versus transurethral resection for symptomatic benign prostatic obstruction: A prospective randomized study with a 2-year follow-up. Br J Urol 1995;76:614-618.
8. de Wildt MJAM, d'Ancona FCH, Hubregtse M, et al. 3 Years' follow-up in patients treated with lower energy thermotherapy (Prosta-soft version 2.0). J Urol 1996;156:1959-1963.
9. Devonec M, Tomera K, Perrin P. Review: Transurethral microwave thermotherapy in benign prostatic hyperplasia. J Endourol 1993;7:255-259.
10. de Wildt MJAM, de la Rosette JJMCH. Review: Transurethral microwave thermotherapy: An evolving technology in the treatment of benign prostatic enlargement. Br J Urol 1995;76:531-538.
11. de la Rosette JJMCH, de Wildt MJAM, Alivizatos G, et al. Transurethral microwave thermotherapy (TUMT) in benign prostatic hyperplasia: Placebo versus TUMT. Urology 1994;44:58-63.
12. Larson TR, Blute ML, Bruskewitz RC, et al. A high-efficiency microwave thermoablation system for the treatment of benign prostatic hyperplasia: Results of a randomized, sham-controlled, prospective, double-blind, multicenter clinical trial. Urology 1998;51:731-742.
13. Ogden CW, Reddy P, Johnson H, et al. Sham versus transurethral microwave thermotherapy in patients with symptoms of benign prostatic bladder outflow obstruction. Lancet 1993;341:14-17.
14. Ahmed M, Bell T, Lawrence WT, et al. Transurethral microwave thermotherapy (Prostatron version 2.5) compared with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: A randomized, controlled, parallel study. Br J Urol 1997:79:181-185.
15. d'Ancona FCH, Francisca EAE, Witjes WP, et al. Transurethral resection of the prostate vs. high-energy thermotherapy of the prostate in patients with benign prostatic hyperplasia: Long-term results. Br J Urol 1998;81:259-264.
16. Floratos DL, Kiemeney LA, Rossi C, et al. Long-term follow-up of a randomized TUMT versus TURP study. J Urol 2001;165:1533-1538.
17. Wagrell L, Schelin S, Nordling J, et al. Feedback microwave thermotherapy versus TURP for clinical BPH: A randomized controlled multicenter study. Urology 2002;60:292-299.
18. Djavan B, Shariat S, Fakhari M, et al. Neoadjuvant and adjuvant alpha-blockade improves early results of high-energy transurethral microwave thermotherapy for lower urinary tract symptoms of benign prostatic hyperplasia: A randomized, prospective clinical trial. Urology 1999;53:251-259.
19. Rosier PFWM, de Wildt MJAM, Wijkstra H, et al. Clinical diagnosis of bladder outlet obstruction in patients with benign prostatic enlargement and lower urinary tract symptoms: Development and urodynamic validation of a clinical prostate score for the objective diagnosis of bladder outlet obstruction. J Urol 1996;155:1649-1654.
20. Djavan B, Larson TR, Blute ML, Marberger M. Transurethral microwave thermotherapy: What role should it play versus medical management in the treatment of benign prostatic hyperplasia? Urology 1998;52:935-947.
21. McConnell JD, Bruskewitz R, Walsh PC, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. N Engl J Med 1998;338:557-563.
22. de la Rosette JJMCH, Kortmann BM, Rossi C, et al. Long-term risk of retreatment of patients using α-blockers for lower urinary tract symptoms. J Urol 2002;167:1734-1739.
23. d'Ancona FCH, Francisca EAE, Witjes WPJ, et al. High energy thermotherapy (TUMT) versus transurethral resection (TURP) in the treatment of benign prostatic hyperplasia (BPH): Results of a prospective randomized study with a 1-year follow-up. J Urol 1997;158:120-125.
24. de la Rosette JJMCH, d'Ancona FCH, Debruyne FMJ. Current status of thermotherapy treatment of the prostate. J Urol 1997;157:430-438.
25. Djavan B, Shariat S, Schafer B, Marberger M. Tolerability of high energy transurethral microwave thermotherapy with topical urethral anesthesia: Results of a prospective, randomized, singleblinded clinical trial. J Urol 1998;160:772-776.
26. de Wildt MJAM, Wagrell L, Larson TR, Eliasson T. Clinical results of microwave thermotherapy for benign prostatic hyperplasia. J Endourol 2000;14:651-656.
27. Devonec M, Dahlstrand C. Temporary urethral stenting after high-energy transurethral microwave thermotherapy of the prostate. World J Urol 1998;16:120-123.
28. Djavan B, Ghawidel K, Basharkhah A, et al. Temporary intraurethral prostatic bridge-catheter compared with neoadjuvant and adjuvant alpha-blockade to improve early results of high-energy transurethral microwave thermotherapy. Urology 1999;54:73-80.
29. Francisca EAE, d'Ancona FCH, Meuleman EJH, et al. Sexual function following high energy microwave thermotherapy: Results of a randomized controlled study comparing transurethral microwave thermotherapy to transurethral prostatic resection. J Urol 1999;161:486-490.
30. Perlmutter A, Perachino M. Mechanism of microwave thermotherapy. World J Urol 1998;16:82-88.
31. d'Ancona FCH, Francisca EAE, Debruyne FMJ, de la Rosette JJMCH. High-energy transurethral microwave thermotherapy in men with lower urinary tract symptoms. J Endourol 1997;11:285-289.
32. Tubaro A, d'Ancona FCH. Case selection for high-energy transurethral microwave thermotherapy. World J Urol 1998;16:124-130.
33. d'Ancona FCH, Albers YH, Kiemeney LA, et al. Can histopathology predict treatment outcome following high-energy transurethral microwave thermotherapy of the prostate? Results of a biopsy study. Prostate 1999;40:28-36.
34. Floratos DL, Sonke GS, Francisca EAE, et al. Long-term follow-up of laser treatment for lower urinary tract symptoms suggestive of bladder outlet obstruction. Urology 2000;56:604-609.
35. Baltussen RMPM, Wielink G, Stoevelaar HJ, et al. The economic impact of introducing transurethral microwave thermotherapy in the treatment of benign prostatic hyperplasia: A scenario analysis. World J Urol 1998;6:142-147.
36. Blute ML, Ackermann SJ, Rein AL, et al. Cost-effectiveness of microwave thermotherapy in patients with benign prostatic hyperplasia II: Results. Urology 2000;56:981-987.
37. Ackerman SJ, Rein AL, Blute ML, et al. Cost-effectiveness of microwave thermotherapy in patients with benign prostatic hyperplasia I: Methods. Urology 2000;56:972-980.
38. Chute CG, Panser LA, Girman CJ, et al. The prevalence of prostatism: A population-based survey of urinary symptoms. J Urol 1993;150:85-89.
39. Stephenson WP, Christopher CC, Guess HA, et al. Incidence and outcome of surgery for benign prostatic hyperplasia among residents of Rochester, Minnesota: 1980-1987. Urology 1991;38:32-42.
40. Donatucci CF, Berger N, Kreder KJ, et al. Randomized clinical trial comparing balloon dilatation to transurethral resection of the prostate for benign prostatic hyperplasia. Urology 1993;42:42-49.
41. Chapple CR, Issa MM, Woo H. Transurethral needle ablation (TUNA): A critical review of radiofrequency thermal therapy in the management of benign prostatic hyperplasia. Eur Urol 1999;35:119-128.
42. Lepor H. Long-term evaluation of tamsulosin in benign prostatic hyperplasia: Placebo-controlled, double-blind extension of Phase III trial. Urology 1998;51:901-906.
43. de la Rosette JJMCH, Alivizatos G, Madersbacher S, et al. EAU guidelines on benign prostatic hyperplasia (BPH). Eur Urol 2000;40:256-263.
44. de la Rosette JJMCH, Francisca EAE, Kortmann BBM, et al. Clinical efficacy of a new 30-min algorithm for transurethral microwave thermotherapy: Initial results. BJU Int 2000;86:47-51.
45. Hoffmann AF, de la Rosette JJMCH, Wijkstra H. Intraprostatic temperature monitoring during transurethral microwave thermotherapy: Status and future developments. J Endourol 2000;14:637-642.